Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)

Interventions

DRUG: Puzolcabtagene Autoleucel Injection

Sponsor

Chongqing Precision Biotech Co., Ltd